HomeCompareRDTCF vs MRK

RDTCF vs MRK: Dividend Comparison 2026

RDTCF yields 2222.22% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RDTCF wins by $26607504688.20M in total portfolio value
10 years
RDTCF
RDTCF
● Live price
2222.22%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26607504688.26M
Annual income
$24,443,703,761,807,280.00
Full RDTCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RDTCF vs MRK

📍 RDTCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRDTCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RDTCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RDTCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RDTCF
Annual income on $10K today (after 15% tax)
$188,888.89/yr
After 10yr DRIP, annual income (after tax)
$20,777,148,197,536,188.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RDTCF beats the other by $20,777,148,197,527,860.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RDTCF + MRK for your $10,000?

RDTCF: 50%MRK: 50%
100% MRK50/50100% RDTCF
Portfolio after 10yr
$13303752344.16M
Annual income
$12,221,851,880,908,540.00/yr
Blended yield
91.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RDTCF
No analyst data
Altman Z
-20.8
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RDTCF buys
0
MRK buys
0
No recent congressional trades found for RDTCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRDTCFMRK
Forward yield2222.22%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$26607504688.26M$56.8K
Annual income after 10y$24,443,703,761,807,280.00$9,798.13
Total dividends collected$26455115546.17M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RDTCF vs MRK ($10,000, DRIP)

YearRDTCF PortfolioRDTCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$232,922$222,222.22$11,206$366.19+$221.7KRDTCF
2$5,086,656$4,837,429.33$12,650$502.35+$5.07MRDTCF
3$104,173,443$98,730,720.93$14,407$694.19+$104.16MRDTCF
4$2,001,166,924$1,889,701,340.37$16,585$967.82+$2001.15MRDTCF
5$36,067,485,611$33,926,237,001.88$19,342$1,363.89+$36067.47MRDTCF
6$610,050,404,477$571,458,194,873.63$22,913$1,947.19+$610050.38MRDTCF
7$9,686,139,336,337$9,033,385,403,546.24$27,662$2,823.89+$9686139.31MRDTCF
8$144,409,519,569,037$134,045,350,479,156.38$34,159$4,173.35+$144409519.53MRDTCF
9$2,022,243,856,495,371$1,867,725,670,556,501.50$43,337$6,308.80+$2022243856.45MRDTCF
10$26,607,504,688,257,330$24,443,703,761,807,280.00$56,776$9,798.13+$26607504688.20MRDTCF

RDTCF vs MRK: Complete Analysis 2026

RDTCFStock

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films, as well as for developing orally delivered vaccine candidate for COVID-19. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.

Full RDTCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RDTCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RDTCF vs SCHDRDTCF vs JEPIRDTCF vs ORDTCF vs KORDTCF vs MAINRDTCF vs JNJRDTCF vs ABBVRDTCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.